MILESTONE — Pattern raises $43 million to pursue FDA clearance
Pattern’s revolutionary Rapid Pneumonia Diagnostic test cuts down result times from days to hours, providing clinicians with the antibiotic guidance needed to quickly and accurately treat critically ill patients. This new funding paired with our recent partnership, creating an intuitive sample prep experience, sets Pattern up for success in their forthcoming commercial launch.








































